FNKO FINAL DEADLINE TUESDAY: ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Funko, Inc. Investors with Losses in Excess of $50K to Secure Counsel Before Important August 1 Deadline in Securities Class Action – FNKO
July 27, 2023 16:15 ET
|
The Rosen Law Firm PA
NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the common stock of Funko, Inc. (NASDAQ: FNKO) between May 6, 2022 and March...
Emerald Health Therapeutics’ Pure Sunfarms JV Records Q3 Net Sales of $24.0 Million, 69% Gross Margin, 56% EBITDA Margin, Fourth Consecutive Quarter of Positive EBITDA, and $0.63/gram All-in Production Cost
November 15, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
Pure Sunfarms is #1 dried flower brand with Ontario Cannabis Store in October, with 16% market share and #1 selling product Emerald to report third quarter 2019 financial results on November 29th and...
Les résultats financiers d'Emerald Health Therapeutics au deuxième trimestre 2019 indiquent un doublement des ventes pour le deuxième trimestre consécutif
August 30, 2019 05:10 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, Colombie-Britannique, 30 août 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV : EMH ; OTCQX : EMHTF) a communiqué aujourd'hui ses résultats financiers...
Emerald Health Therapeutics Reports Second Quarter 2019 Financial Results; Sales Double Second Quarter in a Row
August 29, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today reported financial results for the quarter ended June 30,...